You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning

Article info

Article menu

Download PDFPDF

XML
Oncolytic and local immunotherapy
Short report
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning

Authors

  • Jonathan G Pol McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Institut National de la Santé et de la Recherche Médicale (INSERM), U1138, Paris, France Gustave Roussy Cancer Campus, Villejuif, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Université de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Matthew J Atherton McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Kyle B Stephenson McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Byram W Bridle Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada PubMed articlesGoogle scholar articles
  • Samuel T Workenhe McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Natasha Kazdhan McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • AJ Robert McGray McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Yonghong Wan McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Guido Kroemer Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Institut National de la Santé et de la Recherche Médicale (INSERM), U1138, Paris, France Gustave Roussy Cancer Campus, Villejuif, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Université de Paris, Paris, France Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France Karolinska Institutet, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Brian D Lichty McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles

Citation

Pol JG, Atherton MJ, Stephenson KB, et al
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning
Journal for ImmunoTherapy of Cancer 2020;8:e000981. doi: 10.1136/jitc-2020-000981
Online issue publication 
August 13, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.